Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2022

Feb 24, 2022

3091_iss_2022-02-24_f498af7b-4f56-4acd-a55e-3defb05fea57.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument

Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Date 23/02/2022
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,434,498

Directly held voting rights 0 Indirectly held voting rights 2,434,498 Percentage Directly held shares 3.23342 %

Directly held voting rights 0 % Indirectly held voting rights 3.23342 %

Resulting distribution of total

holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 3.23342 % 2,434,498
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
1.80193 % 1,356,703
Total 5.03535 % 3,791,201

Group total holdings

Voting rights 3,791,201

Percentage of voting rights 5.03535

Notes (other relevant informations according to law)

Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt förvärvat de aktuella värdepapperna.

Published

24/02/2022 10:34

Contact

Name Magnus Westerman

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25